Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S W Langer

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Krankenpflege Journal|June 1, 1996
[Testing the efficacy of a material for the relief of pressure in the prevention and treatment of decubitus ulcers]S W Langer
Sygeplejersken|January 15, 1992
[Breast cancer--which operation?]S W Langer
American Journal of Industrial Medicine|December 1, 1994
Asbestos-induced lung injury among Danish jewelry workersM Døssing, S W Langer
Ugeskrift for Laeger|January 25, 1993
[Affected renal function by ACE inhibitors]S W Langer, M Andersen
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 3, 2001
Dexrazoxane is a potent and specific inhibitor of anthracycline induced subcutaneous lesions in miceS W Langer, M Sehested, P B Jensen
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2000
Treatment of anthracycline extravasation with dexrazoxaneS W Langer, M Sehested, P B Jensen
Sarcoidosis|March 1, 1995
Electrocardiographic changes in patients with intrathoracic sarcoidosis: influence on prognosisS W Langer, E Iversen, J Vestbo, et al.
Ugeskrift for Laeger|January 1, 1996
[Male breast cancer. A review]S W Langer, M Krasnik, F R Hirsch, et al.
Ugeskrift for Laeger|May 15, 1995
[Long-term prognosis of pulmonary sarcoidosis. 2. Cardiac sarcoidosis and other extrapulmonary manifestations]J Vestbo, S W Langer, E T Iversen, et al.
Cancer Treatment Reviews|January 25, 2000
Twenty-five years of chemotherapy in small cell lung cancer sends us back to the laboratoryP B Jensen, M Sehested, S W Langer, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Krankenpflege Journal|June 1, 1996
[Testing the efficacy of a material for the relief of pressure in the prevention and treatment of decubitus ulcers]S W Langer
Sygeplejersken|January 15, 1992
[Breast cancer--which operation?]S W Langer
American Journal of Industrial Medicine|December 1, 1994
Asbestos-induced lung injury among Danish jewelry workersM Døssing, S W Langer
Ugeskrift for Laeger|January 25, 1993
[Affected renal function by ACE inhibitors]S W Langer, M Andersen
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 3, 2001
Dexrazoxane is a potent and specific inhibitor of anthracycline induced subcutaneous lesions in miceS W Langer, M Sehested, P B Jensen
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2000
Treatment of anthracycline extravasation with dexrazoxaneS W Langer, M Sehested, P B Jensen
Sarcoidosis|March 1, 1995
Electrocardiographic changes in patients with intrathoracic sarcoidosis: influence on prognosisS W Langer, E Iversen, J Vestbo, et al.
Ugeskrift for Laeger|January 1, 1996
[Male breast cancer. A review]S W Langer, M Krasnik, F R Hirsch, et al.
Ugeskrift for Laeger|May 15, 1995
[Long-term prognosis of pulmonary sarcoidosis. 2. Cardiac sarcoidosis and other extrapulmonary manifestations]J Vestbo, S W Langer, E T Iversen, et al.
Cancer Treatment Reviews|January 25, 2000
Twenty-five years of chemotherapy in small cell lung cancer sends us back to the laboratoryP B Jensen, M Sehested, S W Langer, et al.
Pageof 3